- New Purchases: APLS, CRSP, ACAD, AVIR, SAGE, PRDS, VTYX, ALNY, CRNX, HALO, LEGN, ARVN, GRPH, AMTI, ADVM, ALGS, VTVT, PCVX, GLUE,
- Added Positions: TSVT, PTGX, GLPG, RCUS, RLAY, VYGR, DSGN, GRTS, NUVB, CNTA,
- Reduced Positions: NRIX, SBTX,
- Sold Out: MRTX, STTK, DRNA, CRVS, BLUE, CYCN, FSII, IGMS, FMTX, BCAB, MGTX, SRRK, ALPN,
For the details of EcoR1 Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ecor1+capital%2C+llc/current-portfolio/portfolio
These are the top 5 holdings of EcoR1 Capital, LLC- Prothena Corp PLC (PRTA) - 11,284,280 shares, 17.76% of the total portfolio.
- AnaptysBio Inc (ANAB) - 7,521,024 shares, 8.33% of the total portfolio.
- Arcus Biosciences Inc (RCUS) - 5,523,358 shares, 7.12% of the total portfolio. Shares added by 7.83%
- Xencor Inc (XNCR) - 4,906,106 shares, 6.27% of the total portfolio.
- Apellis Pharmaceuticals Inc (APLS) - 4,033,882 shares, 6.08% of the total portfolio. New Position
EcoR1 Capital, LLC initiated holding in Apellis Pharmaceuticals Inc. The purchase prices were between $30.74 and $49.16, with an estimated average price of $39.7. The stock is now traded at around $47.070000. The impact to a portfolio due to this purchase was 6.08%. The holding were 4,033,882 shares as of 2021-12-31.
New Purchase: CRISPR Therapeutics AG (CRSP)EcoR1 Capital, LLC initiated holding in CRISPR Therapeutics AG. The purchase prices were between $70.09 and $102.99, with an estimated average price of $86.82. The stock is now traded at around $60.970000. The impact to a portfolio due to this purchase was 2.6%. The holding were 1,077,483 shares as of 2021-12-31.
New Purchase: ACADIA Pharmaceuticals Inc (ACAD)EcoR1 Capital, LLC initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $16.79 and $27.09, with an estimated average price of $20.21. The stock is now traded at around $27.280000. The impact to a portfolio due to this purchase was 2.28%. The holding were 3,060,593 shares as of 2021-12-31.
New Purchase: Atea Pharmaceuticals Inc (AVIR)EcoR1 Capital, LLC initiated holding in Atea Pharmaceuticals Inc. The purchase prices were between $7.67 and $44.59, with an estimated average price of $14.96. The stock is now traded at around $6.420000. The impact to a portfolio due to this purchase was 1.53%. The holding were 5,376,134 shares as of 2021-12-31.
New Purchase: Sage Therapeutics Inc (SAGE)EcoR1 Capital, LLC initiated holding in Sage Therapeutics Inc. The purchase prices were between $37.06 and $47.11, with an estimated average price of $41.81. The stock is now traded at around $43.500000. The impact to a portfolio due to this purchase was 1.28%. The holding were 940,636 shares as of 2021-12-31.
New Purchase: Pardes Biosciences Inc (PRDS)EcoR1 Capital, LLC initiated holding in Pardes Biosciences Inc. The purchase prices were between $10.62 and $17.02, with an estimated average price of $13.8. The stock is now traded at around $10.290000. The impact to a portfolio due to this purchase was 0.83%. The holding were 1,597,139 shares as of 2021-12-31.
Added: 2seventy bio Inc (TSVT)EcoR1 Capital, LLC added to a holding in 2seventy bio Inc by 616.65%. The purchase prices were between $13.77 and $42.56, with an estimated average price of $31.18. The stock is now traded at around $15.200000. The impact to a portfolio due to this purchase was 1.35%. The holding were 1,917,063 shares as of 2021-12-31.
Added: Protagonist Therapeutics Inc (PTGX)EcoR1 Capital, LLC added to a holding in Protagonist Therapeutics Inc by 82.83%. The purchase prices were between $17.63 and $37.1, with an estimated average price of $31.91. The stock is now traded at around $28.730000. The impact to a portfolio due to this purchase was 1.3%. The holding were 2,639,706 shares as of 2021-12-31.
Added: Galapagos NV (GLPG)EcoR1 Capital, LLC added to a holding in Galapagos NV by 42.70%. The purchase prices were between $47.03 and $57.12, with an estimated average price of $52.17. The stock is now traded at around $66.780000. The impact to a portfolio due to this purchase was 1.17%. The holding were 2,224,403 shares as of 2021-12-31.
Added: Relay Therapeutics Inc (RLAY)EcoR1 Capital, LLC added to a holding in Relay Therapeutics Inc by 28.43%. The purchase prices were between $26 and $37.03, with an estimated average price of $31.65. The stock is now traded at around $21.450000. The impact to a portfolio due to this purchase was 0.39%. The holding were 1,779,084 shares as of 2021-12-31.
Added: Voyager Therapeutics Inc (VYGR)EcoR1 Capital, LLC added to a holding in Voyager Therapeutics Inc by 697.66%. The purchase prices were between $2.47 and $5.55, with an estimated average price of $3.41. The stock is now traded at around $3.670000. The impact to a portfolio due to this purchase was 0.27%. The holding were 3,557,507 shares as of 2021-12-31.
Sold Out: Mirati Therapeutics Inc (MRTX)EcoR1 Capital, LLC sold out a holding in Mirati Therapeutics Inc. The sale prices were between $132.01 and $190.29, with an estimated average price of $154.69.
Sold Out: Shattuck Labs Inc (STTK)EcoR1 Capital, LLC sold out a holding in Shattuck Labs Inc. The sale prices were between $8.36 and $20.31, with an estimated average price of $13.53.
Sold Out: (DRNA)EcoR1 Capital, LLC sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.
Sold Out: Corvus Pharmaceuticals Inc (CRVS)EcoR1 Capital, LLC sold out a holding in Corvus Pharmaceuticals Inc. The sale prices were between $2.34 and $5.31, with an estimated average price of $3.84.
Sold Out: bluebird bio Inc (BLUE)EcoR1 Capital, LLC sold out a holding in bluebird bio Inc. The sale prices were between $8.96 and $16.31, with an estimated average price of $11.77.
Sold Out: Cyclerion Therapeutics Inc (CYCN)EcoR1 Capital, LLC sold out a holding in Cyclerion Therapeutics Inc. The sale prices were between $1.56 and $2.95, with an estimated average price of $2.35.
Here is the complete portfolio of EcoR1 Capital, LLC. Also check out:
1. EcoR1 Capital, LLC's Undervalued Stocks
2. EcoR1 Capital, LLC's Top Growth Companies, and
3. EcoR1 Capital, LLC's High Yield stocks
4. Stocks that EcoR1 Capital, LLC keeps buying